The Latest: Drug maker gets money from Germany for vaccine
|
September 4, 2020 7:03 AM
BERLIN -- German pharmaceutical company CureVac says it is receiving a further 252 million euros ($298 million) to develop a coronavirus vaccine.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
